查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881472

胱抑素C檢測市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、方法、樣品類型、應用地區和競爭格局分類，2020-2030年預測

Cystatin C Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Method, By Sample Type, By Application Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球胱抑素C檢測市場規模為3.8554億美元，預計2030年將以6.18%的複合年成長率成長至5.5249億美元。胱抑素C檢測是一種體外診斷測試，可定量測量生物體液（主要是血清或血漿）中的胱抑素C水平，作為評估腎功能和估算腎小球濾過率（GFR）的可靠生物標記。由於胱抑素C水平受肌肉量、年齡或性別等因素的影響較小，因此與基於肌酸酐的檢測相比，此檢測方法具有許多優勢，應用日益廣泛。

市場概覽
預測期 2026-2030
2024年市場規模 3.8554億美元
2030年市場規模 5.5249億美元
2025-2030年複合年成長率 6.18%
成長最快的細分市場 酵素連結免疫吸附試驗（ELISA）
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球胱抑素C檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（分析儀、試劑盒、試劑）
    • 依方法（酵素連結免疫吸附試驗 (ELISA)、顆粒增強濁度免疫測定 (PETIA)、顆粒增強散射比濁免疫測定 (PENIA)、化學發光免疫測定 (CLIA)、免疫螢光測定法 (IFA)、其他）
    • 依樣本類型（血液、尿液）
    • 按應用領域（診斷、研究）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美胱抑素C檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲胱抑素C檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區胱抑素C檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲胱抑素C檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲胱抑素C檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球胱抑素C檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Bio-Techne
  • Agilent Technologies, Inc
  • Gentian Diagnostics ASA
  • Abcam Limited
  • Getein Biotech, Inc
  • Sino Biological, Inc

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22134

The Global Cystatin C Assay Market, valued at USD 385.54 Million in 2024, is projected to experience a CAGR of 6.18% to reach USD 552.49 Million by 2030. A Cystatin C assay is an in vitro diagnostic test that quantitatively measures Cystatin C levels in biological fluids, primarily serum or plasma, serving as a reliable biomarker for assessing renal function and estimating glomerular filtration rate (GFR). This assay is increasingly utilized due to its advantages over creatinine-based tests, as Cystatin C levels are less influenced by factors such as muscle mass, age, or sex.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 385.54 Million
Market Size 2030USD 552.49 Million
CAGR 2025-20306.18%
Fastest Growing SegmentEnzyme-Linked Immunosorbent Assay (ELISA)
Largest MarketNorth America

Key Market Drivers

The market for Cystatin C assays is significantly propelled by the recognized superiority of Cystatin C as an early and accurate renal biomarker. This protein offers a more reliable and precise assessment of glomerular filtration rate because its levels are largely independent of confounding factors such as muscle mass, age, sex, and diet, which often influence creatinine measurements. This intrinsic biological advantage positions Cystatin C as a preferred biomarker for detecting subtle changes in kidney function and facilitating earlier diagnosis. For instance, according to a study published in the Journal of Clinical and Diagnostic Research on March 1, 2024, regression analysis indicated a tighter distribution of results for cystatin C, with an R2 value of 0.67, compared to 0.64 for creatinine, demonstrating its superior predictive ability for GFR.

Key Market Challenges

The elevated cost of Cystatin C reagents and associated testing presents a significant challenge to the widespread growth of the Global Cystatin C Assay Market. This comparative expense, particularly when benchmarked against established and more affordable creatinine assays, directly influences procurement decisions within diverse healthcare systems. The financial disparity strains operational budgets for clinical laboratories, making the adoption of these advanced diagnostics a subject of intense scrutiny regarding cost-effectiveness. Consequently, despite the recognized clinical benefits of Cystatin C assays for more precise renal function assessment, their higher cost hinders broader integration into routine diagnostic panels.

Key Market Trends

The growing demand for automated assay systems represents a significant market trend, driven by the need for enhanced efficiency, reduced manual errors, and increased throughput in clinical laboratories. Automation streamlines complex workflows, from sample handling to result analysis, which is critical for managing high testing volumes and addressing staffing shortages. For instance, the College of American Pathologists, in its 2024 Surveys and Anatomic Pathology Education Programs document, highlighted that it offers more than 700 proficiency testing programs, reflecting the extensive scope of quality assurance in laboratory diagnostics that benefits from automated processes.

Key Market Players

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Bio-Techne
  • Agilent Technologies, Inc
  • Gentian Diagnostics ASA
  • Abcam Limited
  • Getein Biotech, Inc
  • Sino Biological, Inc

Report Scope:

In this report, the Global Cystatin C Assay Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cystatin C Assay Market, By Product:

  • Analyzers
  • Kits
  • Reagents

Cystatin C Assay Market, By Method:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • Particle-enhanced Nephelometric Immunoassay (PENIA)
  • Chemiluminescent immunoassay (CLIA)
  • Immunofluorescence assay (IFA)
  • Others

Cystatin C Assay Market, By Sample Type:

  • Blood
  • Urine

Cystatin C Assay Market, By Application:

  • Diagnostics
  • Research

Cystatin C Assay Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cystatin C Assay Market.

Available Customizations:

Global Cystatin C Assay Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cystatin C Assay Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Analyzers, Kits, Reagents)
    • 5.2.2. By Method (Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), Chemiluminescent immunoassay (CLIA), Immunofluorescence assay (IFA), Others)
    • 5.2.3. By Sample Type (Blood, Urine)
    • 5.2.4. By Application (Diagnostics, Research)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Cystatin C Assay Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Method
    • 6.2.3. By Sample Type
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cystatin C Assay Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Method
        • 6.3.1.2.3. By Sample Type
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Cystatin C Assay Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Method
        • 6.3.2.2.3. By Sample Type
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Cystatin C Assay Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Method
        • 6.3.3.2.3. By Sample Type
        • 6.3.3.2.4. By Application

7. Europe Cystatin C Assay Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Method
    • 7.2.3. By Sample Type
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cystatin C Assay Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Method
        • 7.3.1.2.3. By Sample Type
        • 7.3.1.2.4. By Application
    • 7.3.2. France Cystatin C Assay Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Method
        • 7.3.2.2.3. By Sample Type
        • 7.3.2.2.4. By Application
    • 7.3.3. United Kingdom Cystatin C Assay Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Method
        • 7.3.3.2.3. By Sample Type
        • 7.3.3.2.4. By Application
    • 7.3.4. Italy Cystatin C Assay Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Method
        • 7.3.4.2.3. By Sample Type
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Cystatin C Assay Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Method
        • 7.3.5.2.3. By Sample Type
        • 7.3.5.2.4. By Application

8. Asia Pacific Cystatin C Assay Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Method
    • 8.2.3. By Sample Type
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cystatin C Assay Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Method
        • 8.3.1.2.3. By Sample Type
        • 8.3.1.2.4. By Application
    • 8.3.2. India Cystatin C Assay Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Method
        • 8.3.2.2.3. By Sample Type
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Cystatin C Assay Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Method
        • 8.3.3.2.3. By Sample Type
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Cystatin C Assay Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Method
        • 8.3.4.2.3. By Sample Type
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Cystatin C Assay Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Method
        • 8.3.5.2.3. By Sample Type
        • 8.3.5.2.4. By Application

9. Middle East & Africa Cystatin C Assay Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Method
    • 9.2.3. By Sample Type
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cystatin C Assay Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Method
        • 9.3.1.2.3. By Sample Type
        • 9.3.1.2.4. By Application
    • 9.3.2. UAE Cystatin C Assay Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Method
        • 9.3.2.2.3. By Sample Type
        • 9.3.2.2.4. By Application
    • 9.3.3. South Africa Cystatin C Assay Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Method
        • 9.3.3.2.3. By Sample Type
        • 9.3.3.2.4. By Application

10. South America Cystatin C Assay Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Method
    • 10.2.3. By Sample Type
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cystatin C Assay Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Method
        • 10.3.1.2.3. By Sample Type
        • 10.3.1.2.4. By Application
    • 10.3.2. Colombia Cystatin C Assay Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Method
        • 10.3.2.2.3. By Sample Type
        • 10.3.2.2.4. By Application
    • 10.3.3. Argentina Cystatin C Assay Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Method
        • 10.3.3.2.3. By Sample Type
        • 10.3.3.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cystatin C Assay Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. F. Hoffmann-La Roche Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories Inc.
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Siemens Healthineers AG
  • 15.5. Bio-Techne
  • 15.6. Agilent Technologies, Inc
  • 15.7. Gentian Diagnostics ASA
  • 15.8. Abcam Limited
  • 15.9. Getein Biotech, Inc
  • 15.10. Sino Biological, Inc

16. Strategic Recommendations

17. About Us & Disclaimer